New way to administer CAR-T-cell therapy could lead to fewer side effects

When Richard O’Neil, Ph.D., joined MUSC Hollings Cancer Center two years ago, he knew that he wanted to continue finding ways to make CAR-T-cell therapy easier on patients.

New tool predicts health risks from heat and cold waves

Ambient temperatures are associated with over 5 million premature deaths worldwide every year, more than 300,000 of which in Western Europe alone.

June 26, 2024

Uncovering hidden drug benefits through protein mapping

Fewer side effects, improved chances of healing: the goal of precision medicine is to provide patients with the most individualized treatment possible. This requires a

August 2, 2024

ASCO 2024: Merus touts positive Phase II data for head and neck cancer antibody – Pharmaceutical Technology

Merus’s bispecific antibody petosemtamab targets epidermal growth factor receptor (EGFR) and leucine-rich repeat-containing G-protein coupled receptor 5 (LGR5). Credit: MacroEcon via Shutterstock. Amongst abstracts announced

May 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.